Your browser doesn't support javascript.
loading
Systemic Lupus Erythematosus and Cytokine Storm.
Caricchio, Roberto; Gallucci, Stefania.
Affiliation
  • Caricchio R; UMass Chan Medical School, Worcester, MA, USA. Lupus.Caricchio@umassmed.edu.
  • Gallucci S; UMass Chan Medical School, Worcester, MA, USA.
Adv Exp Med Biol ; 1448: 355-364, 2024.
Article de En | MEDLINE | ID: mdl-39117826
ABSTRACT
Systemic lupus erythematosus (SLE) is the prototype of autoimmune diseases and can manifest with a plethora of clinical signs and symptoms associated with a myriad of laboratory abnormalities. An infrequent but potentially lethal complication of SLE is macrophage activation syndrome (MAS). The diagnosis of MAS in SLE can be very challenging due to similarities in presentation of both flares and infections, such as fever, lymphadenopathy, splenomegaly, and cytopenias. These aggravating factors contribute to the increased risk of poor outcomes in SLE-associated MAS. Indeed, at the moment MAS remains invariably lethal if untreated and still has a high mortality rate with treatment. In this chapter, we discuss several aspects of MAS in the context of SLE and in particular, the pathogenesis of MAS in SLE, how MAS presents in pediatric versus adult SLE, and, finally, MAS treatment in SLE and future directions.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome d'activation macrophagique / Lupus érythémateux disséminé Limites: Humans Langue: En Journal: Adv Exp Med Biol Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Syndrome d'activation macrophagique / Lupus érythémateux disséminé Limites: Humans Langue: En Journal: Adv Exp Med Biol Année: 2024 Type de document: Article Pays d'affiliation: États-Unis d'Amérique Pays de publication: États-Unis d'Amérique